Dr. John C. McCann
Claim this profileBaystate Medical Center
Area of expertise
Lung Cancer
John C. McCann has run 8 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
John C. McCann has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Baystate Medical Center
Clinical Trials John C. McCann is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Nivolumab + Ipilimumab + Sargramostim
for Advanced Melanoma
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Colony-stimulating factors, such as sargramostim, may increase the production of white blood cells. It is not yet known whether nivolumab and ipilimumab are more effective with or without sargramostim in treating patients with melanoma.
Recruiting
1 award
Phase 2 & 3
23 criteria
More about John C. McCann
Clinical Trial Related
2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments John C. McCann has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Pemetrexed
- Dabrafenib Mesylate
- Carboplatin
Breakdown of trials John C. McCann has run
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John C. McCann specialize in?
John C. McCann focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is John C. McCann currently recruiting for clinical trials?
Yes, John C. McCann is currently recruiting for 4 clinical trials in Springfield Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that John C. McCann has studied deeply?
Yes, John C. McCann has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with John C. McCann?
Apply for one of the trials that John C. McCann is conducting.
What is the office address of John C. McCann?
The office of John C. McCann is located at: Baystate Medical Center, Springfield, Massachusetts 01199 United States. This is the address for their practice at the Baystate Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.